---
title: "Annovis Bio (ANVS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ANVS.US/norm.md"
symbol: "ANVS.US"
name: "Annovis Bio"
parent: "https://longbridge.com/en/quote/ANVS.US.md"
datetime: "2026-06-13T13:16:12.544Z"
locales:
  - [en](https://longbridge.com/en/quote/ANVS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ANVS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ANVS.US/norm.md)
---

# Annovis Bio (ANVS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.6322 | -0.3845 | -0.3700 | -0.3200 | -0.3200 |
| ROE | -705.06% | -262.19% | -184.53% | -117.40% | -132.78% |
| Revenue | - | - | - | - | - |
| Net income | -17.61M | -9.83M | -7.26M | -6.22M | -5.54M |
| Operating income | -18.01M | -9.71M | -7.43M | -6.27M | -6.28M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 16.24M | 21.08M | 17.19M | 21.45M | 26.74M |
| Leverage | 5.20 | 1.25 | 1.31 | 1.17 | 1.11 |
| BVPS | 0.1095 | 0.6196 | 0.6517 | 0.9407 | 1.23 |
| Turnover | - | - | - | - | - |
| Cash & STI | 14.22M | 19.53M | 15.29M | 17.13M | 22.24M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -14.22M | -19.53M | -15.29M | -17.13M | -22.24M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | -8.93M | -3.49M | -5.11M | -8.10M |
| Investing CF | - | - | - | - | - |
| Financing CF | - | 13.17M | 1.64M | 0.0000 | 19.78M |
| Free CF | - | -5.45M | -851816.00 | -2.95M | -5.93M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |